@GeneInvesting Maybe the next in line after NTLA is Fractyl’s GLP‑1 gene therapy play. 👀
Wild to see how fast the field is moving , one shot instead of lifelong injectables?
https://t.co/4x1zZkxzXH
@GeneInvesting@GrzegorzPko Given what happened, how are you thinking about your exit strategy now? Planning to scale out little by little or sell everything once your targets hit?
@GeneInvesting Hi! after CRISPR’s impact in medicine, what’s the next breakthrough theme you’re watching Psychedelic‑based therapeutics like $DFTX?
Telomere biology? iPSC platforms? Curious where you see the next big wave in biotech innovation.
@GeneInvesting Let’s keep it cool, mi gente. No need for X wars over $NTLA. We all want the same thing — smooth sailing and good karma. Higher road always
@GeneInvesting The devastating reality of stock market math: a 70% drop from $40 to $12, but it takes an astonishing 233% gain to bounce back. Brutally unfair and painfully clear.
@GeneInvesting Let's say NTLA stock jumps to $50 tomorrow. What's a good strategy? Should we sell or keep buying NTLA, or diversify by buying BEAM or SANA?